WE FOCUS ON SUSTAINABLE & LONG-TERM COOPERATION
Our network is made up of first-class suppliers and competent partners. They are the guarantor for constant innovation and qualified cooperation.
We also invest our resources in scientific partnerships. We work with them on joint projects, are in constant communication and thus create added value for all parties involved. Made possible by the good cooperation with AQT (Alpine Quantum Technologies), CERN, DESY (Deutsches Elektronen-Synchrotron) and MCI (Management Center Innsbruck).
STRATEGIC PARTICIPATION AND COOPERATION WITH ALUMINA SYSTEMS
With effect from December 31, 2024, SWACRIT acquired a strategic stake in the German company Alumina Redwitz Holding GmbH via SWACRIT Technologies AG. Alumina Redwitz Holding GmbH is the parent company of the Alumina Systems Group (“Alumina”). Alumina, formerly part of the Siemens Group, develops and produces ceramic components for demanding and mission-critical industrial applications and has unique expertise in vacuum-tight ceramic-to-metal composite components. By investing in Alumina as a developer and manufacturer of vacuum-tight ceramic-to-metal composite components, SWACRIT becomes a unique system supplier in Europe and expands its target markets and production footprint.
Visit the website chevron_right
Research & Development
creating great things together
Cooperation
Research and development are part of our mindset, which is why we are particularly pleased when we can collaborate on research projects and generate concrete additional benefits. One concrete example of this is the eVITA (electrical Vestibular Implant Tyrol Austria) project – the development of a vestibular implant.
eVITA
A disorder of the organ of balance, also known as the vestibular organ, leads to problems with movement and visual perception. The result is dizziness with nausea and vomiting, and vision is also severely impaired. The information received by the eye can no longer be processed correctly by the brain if the information from the sense of balance for image stabilization is missing. This causes an increased risk of falling and a massive reduction in quality of life. 500,000 people in Europe and the USA are affected. A biotechnical prosthesis that replaces the affected sensory organ is intended to provide a remedy. The nerve cells of the vestibular organ are specifically stimulated via electrical impulses in order to compensate for the loss of the sensory cells. This goal can only be achieved on an interdisciplinary basis by combining the relevant expertise in the fields of biomedical informatics, microanatomy and physiology of the inner ear, as well as the innovative professionalism of reliable manufacturing experts. The project partners of eVITA are the University Hospital Innsbruck, UMIT TIROL with the Institute for Biomedical Image Analysis (IBIA), Innsbruck-based MED-EL GmbH, a world leader in the field of hearing implants, SWACRIT systems as an expert in the manufacture of medical products in the µ range, and LaiTronic GmbH for the development of a motion capture system.
This ambitious and equally important project was funded by the province of Tyrol as part of the K-Regio program, co-financed by the European Regional Development Fund (ERDF).
